Who
Caroline Dorsa
Director
Company insider
Files Form 4 as: Director, Illumina; Director, Duke Energy Corporation (Holding Company); Director, Biogen; Director, Intellia Therapeutics; Executive VP & CFO, Public Service Enterprise Group; SVP, Chief Financial Officer, Gilead Sciences; SVP & Chief Financial Officer, Avaya; V.P. & Treasurer, Merck & Co.
In numbers
- Trades disclosed
- 190
- Buys
- 13
- Sells
- 8
- Bought
- $435K
- Sold
- $20.6M
- Companies
- 8
- Companies where not an officer
- 4
- First trade
- 7 Feb 2006
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 20 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $215K1,512 at $141.92 | filing |
| 20 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $215K1,512 at $141.92 | filing |
| 7 May 2026filed 11 May 2026 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $200K1,602 at $124.87 | filing |
| 7 May 2026filed 11 May 2026 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $200K1,602 at $124.87 | filing |
| 17 Jun 2025filed 18 Jun 2025 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —3,160 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —3,780 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $89K1,070 at $83.62 | filing |
| 2 May 2025filed 5 May 2025 | BIIB BiogenBiotechnology | SEC FORM 4 Bought | $152K1,235 at $122.72 | filing |
| 1 May 2025filed 5 May 2025 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $195K1,607 at $121.33 | filing |
| 21 Jun 2024filed 25 Jun 2024 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,785 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —2,622 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $70K612 at $115.01 | filing |
| 9 May 2024filed 13 May 2024 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $175K1,698.7 at $103.02 | filing |
| 26 Jun 2023filed 28 Jun 2023 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,580 at $0.00 | filing |
| 26 May 2023filed 31 May 2023 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —1,532 at $0.00 | filing |
| 24 May 2023filed 25 May 2023 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $105K492 at $212.65 | filing |
| 4 May 2023filed 8 May 2023 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $175K1,783.71 at $98.11 | filing |
| 15 Jun 2022filed 17 Jun 2022 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,370 at $0.00 | filing |
News
Morgan Stanley Has Lowered Expectations for Public Service Enterprise Group (NYSE:PEG) Stock PricePEG · dailypolitical.com · 21 Oct 2026Illumina To Webcast Upcoming Investor ConferenceILMN · prnewswire.com · 20 Oct 2026Contrasting Intellia Therapeutics (NASDAQ:NTLA) and BeyondSpring (NASDAQ:BYSI)NTLA · tickerreport.com · 19 Oct 2026Financial Review: Intellia Therapeutics (NASDAQ:NTLA) versus Spyre Therapeutics (NASDAQ:SYRE)NTLA · themarketsdaily.com · 19 Oct 2026Biogen (NASDAQ:BIIB) Hits New 52-Week High Following Analyst UpgradeBIIB · dailypolitical.com · 14 Oct 2026Intellia Therapeutics Names New CMO To Oversee Clinical And Regulatory FunctionsNTLA · rttnews.com · 13 Oct 2026Illumina's (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself?ILMN · insidermonkey.com · 13 Oct 2026Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?BIIB · insidermonkey.com · 13 Oct 2026
0 headlines in the last 90 days name Caroline Dorsa; 9 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.